Fighting against thymic cancer: conventional treating options and advances
Download as PDF
DOI: 10.23977/behdp.2021031
Corresponding Author
Siyu Hu
ABSTRACT
The passage mainly talks about the treatment of thymic cancer. The chemotherapy uses doxorubicin, cisplatin, and carboplatin for the drugs of thymic cancer, and the side effects of those drugs. Doxorubicin, cisplatin, and carboplatin need to be injected through veins. Doxorubicin has side effects like hair loss, cisplatin has disadvantages like damage to the kidney, carboplatin such as severe allergy. The chemotherapy that using Hyperthermic Intrathoracic Chemotherapy (HITHOC) that use high temperature to kill cancer cell and remove residual cancer cells inside the body. And the introduction of adjuvant treatment and neoadjuvant therapy, the information of a combination of chemo radiotherapy. Adjuvant treatment that helps decrease the ability of cancer cells that come back to patients’ body. Neoadjuvant treatments include chemotherapy, radiation therapy, and hormone therapy to reduce the size of a tumor. Differences between adjuvant therapy and neoadjuvant treatment are that adjuvant is usually after the surgery that makes sure the chances of getting cancer again is smaller, and neoadjuvant usually before the surgery that decreases the size of the tumor. Chemoradiotherapy uses both drugs and radiation to kill cancer cells. Also, the radiotherapy involved in External Beam Radiation Therapy (EBRT) that helps to shrink tumors.
KEYWORDS
Doxorubicin, Cisplatin, Carboplatin, Thymic Cancer, Chemoradiotherapy, Radiotherapy